Are MMSE and HDS-R neuropsychological tests adequate for screening HIV-associated neurocognitive disorders?

J Infect Chemother. 2014 Mar;20(3):217-9. doi: 10.1016/j.jiac.2013.10.005. Epub 2014 Jan 18.

Abstract

HIV-associated neurocognitive disorders (HAND) are one of major comorbidities in patients with HIV-1 infection. There are currently no standardized tests for screening HAND in such patients. The sensitivity of the cognitive function tests routinely used in clinical practice, such as the Mini-Mental State Examination and the Revised Hasegawa's Dementia Scale, is inadequate to rule out HAND, even in patients with clear abnormal behavior. We report a 41-year-old man with HIV-associated dementia, the most severe form of HAND, in whom the simplified methods did not show abnormal results, and a comprehensive battery of neuropsychological tests which covering several cognitive domains was needed to detect cognitive impairment.

Keywords: Cognitive domain; Cognitive impairment; HIV-associated neurocognitive disorders; Neuropsychological test; cART.

Publication types

  • Case Reports

MeSH terms

  • AIDS Dementia Complex / diagnosis*
  • Adult
  • Brain / pathology
  • Brain / physiopathology
  • Cognition Disorders / diagnosis*
  • Cognition Disorders / virology*
  • HIV Infections / psychology*
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Neuropsychological Tests*